Rocket


News + Filings
Key Docs
Charts
Holdings
Ownership





All
13F
13D/G
Other



NESTLE SA (NSRGY) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/17/2022 4 Societe des Produits Nestle S.A. (10% Owner) has filed a Form 4 on Axcella Health Inc.
Txns: Bought 3,658,536 shares @ $1.64, valued at $6M
03/16/2022 4 Societe des Produits Nestle S.A. (10% Owner) has filed a Form 4 on Axcella Health Inc.
Txns: Bought 3,141,361 shares @ $1.91, valued at $6M
03/12/2021 3 NESTLE SA (10% Owner) has filed a Form 3 on Prometheus Biosciences, Inc.
09/09/2020 4 Societe des Produits Nestle S.A. (10% Owner) has filed a Form 4 on Axcella Health Inc.
Txns: Acquired 4,305,541 shares @ $4.42, valued at $19M
05/21/2020 4 Nestle Health Science US Holdings, Inc. (10% Owner) has filed a Form 4 on Axcella Health Inc.
Txns: Bought 1,936,842 shares @ $4.75, valued at $9.2M
04/24/2020 4 Societe des Produits Nestle S.A. (10% Owner) has filed a Form 4 on Aimmune Therapeutics, Inc.
Txns: Bought 1,000,000 shares @ $31.97, valued at $32M
Bought 525,634 preferred shares @ $319.675, valued at $168M
Acquired 12,727,113 shares @ $16.11, valued at $205M
Acquired 525,634 preferred shares @ $161.1, valued at $84.7M
04/24/2020 3 Nestle Health Science US Holdings, Inc. (10% Owner) has filed a Form 3 on Aimmune Therapeutics, Inc.
04/24/2020 4 Nestle Health Science US Holdings, Inc. (10% Owner) has filed a Form 4 on Aimmune Therapeutics, Inc.
Txns: Bought 937,500 shares @ $32, valued at $30M
Bought 3,237,529 shares @ $30.27, valued at $98M
02/14/2020 3 Nestle Health Science US Holdings, Inc. (10% Owner) has filed a Form 3 on Axcella Health Inc.
11/23/2016 3 Nestle Health Science US Holdings, Inc. (10% Owner) has filed a Form 3 on Aimmune Therapeutics, Inc.
07/01/2015 4 Nestle Health Science US Holdings, Inc. (10% Owner) has filed a Form 4 on Seres Therapeutics, Inc.
Txns: Granted 1,333,333 shares @ $18, valued at $24M
06/29/2015 4 Nestle Health Science US Holdings, Inc. (10% Owner) has filed a Form 4 on Seres Therapeutics, Inc.
Txns: Converted 3,611,111 shares @ $0
Converted 3,611,111 convertible preferred @ $0
07/07/2009 F-6EF Form F-6EF -- Registration of American Depostory Receipt shares, immediately effective
07/03/2008 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
12/29/2005 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
11/30/2005 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
11/22/2005 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
11/04/2005 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
09/07/2005 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party:
07/07/2005 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
02/12/2003 SC 13G NESTLE SA reports a 74.5% stake in Alcon, Inc.
02/27/1998 SC 13G/A NESTLE SA reports a 13.7% stake in TRANSCEND THERAPEUTICS, INC.
02/17/1998 5 Form 5 -- Annual statement of changes in beneficial ownership of securities
02/05/1998 SC 13G NESTLE SA reports a 13.7% stake in TRANSCEND THERAPEUTICS, INC.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy